Can CBD help to combat COVID variants?

Authors

DOI:

https://doi.org/10.25250/thescbr.brk704

Keywords:

COVID-19, SARS-CoV-2, Cannabidiol (CBD), Cannabis

Abstract

There is an urgent need to find new treatments that complement the use of vaccines and antiviral drugs to combat the COVID-19 pandemic.  Our interdisciplinary research team uncovered evidence that cannabidiol (CBD), a non-psychoactive compound produced by cannabis plants, has the potential to inhibit SARS-CoV-2, the virus that causes COVID.

Author Biographies

  • Marsha Rosner, University of Chicago

    Professor

  • Long Nguyen, University of Chicago

    Postdoctoral Research Fellow

Original article reference

Nguyen, L. C., Yang, D., Nicolaescu, V., Best, T. J., Gula, H., Saxena, D., Gabbard, J. D., Chen, S.-N., Ohtsuki, T., Friesen, J. B., Drayman, N., Mohamed, A., Dann, C., Silva, D., Robinson-Mailman, L., Valdespino, A., Stock, L., Suárez, E., Jones, K. A., … Rosner, M. R. (2022). Cannabidiol inhibits SARS-CoV-2 replication through induction of the host ER stress and innate immune responses. Science Advances, 8(8). https://doi.org/10.1126/sciadv.abi6110

Downloads

  • URL

Published

2023-05-17

Issue

Vol. 9 No. 2 (2023): TheScienceBreaker

Section

Health & Physiology

License

Copyright (c) 2023 Marsha Rosner, Long Nguyen

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.